Moderna, Inc. vs Transocean Ltd — how do they compare? Moderna, Inc. trades at $59.68 (market cap $23.60B), while Transocean Ltd trades at $5.23 (market cap $5.56B). The key difference: Moderna, Inc. is far larger — about 4.2× Transocean Ltd's market cap, and Moderna, Inc. is trading nearer its 52-week high, Transocean Ltd nearer its low. Which is the better fit depends on your goals.
| MRNA | RIG | |
|---|---|---|
Market Cap | $23.60B | $5.56B |
Sector | Health | Technology |
52-Week High | $81.80 | $7.58 |
52-Week Low | $22.36 | $2.64 |
Enterprise Value | $19.70B | $10.50B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →